Purpose: There is extensive evidence regarding the relationship between HIV related stigma and disclosure; however, the influence of depression in this relationship is not well understood, and thus is the focus of our analysis. Methods: Baseline data from a prospective longitudinal cohort of 798 HIV patients starting ART in Kampala, Uganda were examined. A staged-approach regression analysis was used to examine variables associated with HIV disclosure to most people (general disclosure) and disclosure to primary sex partner. Internalized HIV stigma plus demographic and background covariates were first entered into the model; the binary indicator of clinical depression was added on step two, followed by the addition of the interaction of stigma and depression in step three. Separate analyses were conducted for each of the two disclosure outcomes. Results: 39% indicated that they kept their HIV status as a secret from most people, while 19% of respondents with a regular sex partner had not disclosed their HIV status to the partner. In bivariate analysis, respondents who preferred to keep their HIV status as a secret from most people had higher internalized HIV stigma (p < 0.001) and depression (p < 0.01), and were more likely to be clinically depressed (p < 0.01) compared with others in the sample. Similarly, participants who had not disclosed their HIV status to their main sex partner had higher internalized HIV stigma (p < 0.01) and depression (p < 0.05), and were more likely to be clinically depressed (p < 0.01) compared with those who had informed their partner of their HIV status. The regression analysis revealed that internalized HIV stigma was strongly negatively correlated with disclosure to primary partner, while depression was not associated. In the regression analysis for general disclosure, both stigma and depression were negatively correlated with disclosure when the interaction term was included in the model. Further analysis showed that internalized HIV stigma was more strongly associated with general disclosure among participants who were not depressed. Conclusions: Although there was clearly a strong and consistent association between internalized HIV stigma and depression symptoms, the strong association between internalized HIV stigma and * Corresponding author.
Introduction
Advances in diagnosis, treatment, and care of HIV infection including the use of antiretroviral therapy (ART) have transformed HIV/AIDS from an acute deadly illness to a manageable chronic illness. However, HIV remains a highly stigmatized disease and evidence shows that fear of stigma and discrimination may deter people from disclosing their HIV status to sexual partners, family and friends, which can impede prevention efforts such as promotion of HIV testing and condom use [1] - [6] . Disclosure to ones' significant others brings with it a host of potential consequences, some positive and some negative [5] [7] - [10] . The consequence theory of HIV disclosure suggests that disclosure is moderated by the consequences one anticipates resulting from the disclosure [11] . The theory postulates that persons with HIV are likely to reveal their HIV sero-status to significant others and sexual partners once the rewards for disclosing outweigh the associated costs. Derlega and others found that HIV-positive individuals used a selective disclosure process to reduce risks and increase benefits of disclosure [12] . Consequently, HIV-positive individuals disclose to those who pose little risk while avoiding disclosing to those who could harm them. Identifying factors associated with disclosure could help to inform how people living with HIV make disclosure decisions and thus how to support effective disclosure decision making and outcomes.
Studies that have documented prevalence of HIV disclosure in Sub-Saharan Africa have shown that the rates vary substantially in different populations. Studies focusing on rates of disclosure to primary sex partners have reported disclosure rates ranging from 16.7% to 90.2% in Tanzania, Kenya, Ethiopia, Rwanda, Burkina Faso, South Africa and the Democratic Republic of Congo [5] [9] [13] - [20] . Studies conducted in South Africa, Uganda and Ethiopia of more general disclosure, representing disclosure to people in one's social network including family, friends and others, reveal varying rates of between 18% to 95% [6] [9] [21]- [23] .
Studies on disclosure among persons living with HIV in Sub-Saharan Africa have identified several variables that have demonstrated correlation with disclosure. Several studies have indicated that HIV-infected individuals are more likely to disclose to a partner whom they know is HIV-positive than to an HIV-negative or unknown sero-status partner [24] [25] . Study by Mansergh and others found positive correlation between illness severity, length of time since HIV diagnosis and disclosure [26] . Research on partnership variables has demonstrated that "main/steady/regular" partnerships are more likely to involve disclosure than "other/casual/unfamiliar" partnerships [27] [28] . Another factor associated with disclosure was social support-individuals with high social support tend to disclose their result more often than those without such support [29] . Studies conducted in Tanzania and Ethiopia a strong association between prior communication about HIV testing with a partner and HIV-serostatus disclosure [10] [19] .
Internalized stigma is believed to be a key determinant to disclosure. Several studies have attempted to assess the relationship between stigma and disclosure [9] [30] . There is a complex relationship between an individual's psychological state and feelings of being stigmatized and it's possible that depression may influence how internalized stigma relates to HIV disclosure. For example, if someone is depressed, the internalized stigma that they feel may impede even more so their comfort with disclosing their HIV status, whereas if the person is not depressed they may feel that they have adequate resources to cope with the risks associated with disclosure and thus assess the potential benefits of disclosure to outweigh the costs. However, how depression influences the relationship between internalized stigma and disclosure is not clear. Establishing this relationship is important if interventions that seek to promote disclosure and increase positive disclosure outcomes and secondary prevention of HIV are to be effective. This analysis focuses on the relationship between internalized HIV stigma and disclosure of HIV status, and how depression may influence this relationship.
Methods

Study Design and Setting
Participants were enrolled in a longitudinal prospective cohort study designed to examine the effects of depression and antidepressant treatment on multiple health outcomes of ART. Participants were followed for one year from the start of ART, but the analysis for this paper was based solely on data collected at baseline, prior to the start of ART and antidepressant therapy. Participants were enrolled at four HIV clinics operated by Mildmay Uganda, in urban Kampala and the rural towns of Mityana, Naggalama and Mukono. These clinics generally serve clients in the lower socioeconomic strata and who work in the informal labor market.
Sample
Clients 18 years or older who had just been prescribed ART by their primary care provider, and agreed to start treatment, were eligible for enrollment. At each study clinic, the primary eligibility criteria for initiation of ART were a CD4 cell count ≤ 250 cells/mm 3 or a diagnosis of WHO HIV disease stage III or IV (AIDS diagnosis). Between September 2010 and February 2011, clients were enrolled consecutively at the visit during which their eligibility for ART was determined. All participants were required to provide written informed consent. The study protocol was approved by Institutional Review Boards at RAND and Makerere University, as well as the Uganda National Council of Science and Technology.
Measures
All measures were interviewer-administered in Luganda, the most common language in this region of Uganda. The entire questionnaire was translated into Luganda using standard translation and back-translation methodology. Masters level psychologists were trained to administer the study assessments.
Depression: The 9-item Patient Health Questionnaire (PHQ-9) was used to measure the presence of depressive symptoms over the past 2 weeks. Each of the 9 items corresponds to the symptoms used to diagnose depression according to DSM (Diagnostic and Statistics Manual of Mental Disorders) criteria; responses to each item range from 0 "not at all" to 3 "nearly every day". Items were summed with a possible range of 0 -27, and scores > 9 signifies clinical depression and correspond highly to major depression as determined by a diagnostic clinical interview [31] . The items were divided into somatic (4 items: fatigue, difficulty sleeping, poor appetite/ overeating, psychomotor retardation) and cognitive symptoms (5 items: depressed mood, loss of interest, feeling bad about oneself, trouble concentrating, suicidal thoughts) of depression to create somatic and cognitive subscales, with each subscale being the sum of the included items. The PHQ-9 has been used successfully with HIV-infected individuals in other studies within Sub-Saharan Africa [32] .
Internalized HIV stigma: was assessed with an 8-item scale developed by Kalichman and others [33] . Examples of items include "Being HIV positive makes me feel damaged" and "I am ashamed that I am HIV positive"; response options range from 1 "disagree strongly" to 5 "agree strongly", and a mean item score is calculated. Higher scores represent greater stigma.
Disclosure: To measure general disclosure, participants were asked, "Do you generally keep your HIV status a secret from people?" A yes or no response was elicited. We also assessed disclosure to sex partners. Those who reported being married or in a committed relationship, or had a regular sex partner, were asked if they had disclosed to this partner. Responses options for both of these questions were "Yes" or "No". Participants who reported having casual sex partners (defined as a non-regular partner or partner not in a relationship with) in the past 6 months were asked, "To what extent did you disclose your HIV status to these other partners?" Response options included "did not disclose to any", "disclosed to some", and "disclosed to all"; a binary variable was then created to indicate whether or not all casual partners had been disclosed to.
Demographic and background characteristics: included age, sex, education level (classified as primary school or less vs. at least some secondary education), relationship status (binary indicator of whether the participant was married or in a committed relationship versus single, divorced or widowed), work status (binary indicator of any income or food generating activity in the past 7 days) and urban (those attending the Kampala clinic) versus rural (attending one of the other three clinics) location.
Data Analysis
Bivariate statistics (2-tailed independent t-tests; Chi Square tests) were used to examine the associations be-tween the binary HIV disclosure variables and measures of depression and internalized HIV stigma, as well as between depression and stigma (Pearson correlations). To examine how depression influences the relationship between internalized HIV stigma and HIV disclosure, we used a staged approach to our logistic regression analysis of variables associated with HIV disclosure. First, only internalized HIV stigma was included in the model in addition to demographic (age, sex, secondary education) and background (work status, clinic site) covariates. On the second step, the binary depression variable representing clinical depression was added to the model. Lastly, the interaction of stigma and depression was added to the model along with the main effects of stigma and depression. When the interaction term was significant, we conducted separate regression analyses for the clinically depressed and non-depressed subgroups to examine the relationship between internalized HIV stigma and disclosure, controlling for the covariates. Separate analyses were performed for general disclosure and disclosure to primary sex partner; analysis was not conducted for disclosure to casual partners because of the low number of participants with such partners and lack of significant bivariate correlates of such disclosure. For the inclusion of site in the regression models, the Kampala site served as the reference group. Table 1 lists the sample's demographic and medical characteristics. Two thirds of the study sample was female, few (15%) had any secondary education, and most (66%) were working in the past week. Just under one-third (32%) was married, and another 12% were in a committed relationship; in addition, 24% were not married or in a committed relationship, but reported having a regular sex partner. The HIV status of the primary partner consisted of 46% being HIV-positive, 17.6% HIV-negative, and 36.6% being of unknown HIV status. Most of the total sample (86%) had a CD4 count of 250 or less, but only 19% had WHO disease stage III or IV. Mean PHQ-9 score was 3.97 (SD = 4.48); 12.5% had scores > 9, which signifies clinical depression, and another 19.4% had minor depression (scores of 5 -9). 
Results
Sample Description
Prevalence of HIV Disclosure
Regarding general disclosure of HIV status, 39% indicated that they kept their HIV status a secret from most people. Of the 425 participants who had a main sex partner (includes married, in a committed relationship or has a regular sex partner), 81% reported that they had disclosed their HIV status to this partner. Only 65 participants reported having casual sex partners in the 6 months prior to interview, of whom 34% had disclosed their HIV status to all such partners.
Bivariate Correlates of HIV Disclosure
Participants who preferred to keep their HIV status a secret from most people had higher internalized HIV stigma (mean = 2.67 vs. Also, the respondent was much more likely to have disclosed their HIV status to their primary partner if the partner was HIV-positive (100%) or HIV-negative (95%) compared to if the partner's status was unknown (52%) (p < 0.000). Among the participants who had casual sex partners, those who had disclosed to all such partners did not differ significantly from those who had not disclosed to all partners with regard to internalized stigma, depression and presence of clinical depression. Internalized HIV stigma was positively correlated with depression (r = 0.40; p < 0.001), and those with clinical depression had higher internalized stigma (mean = 3.06 vs. 2.13; p < 0.001) compared to those who were not depressed (see Table 2 ).
Multivariate Regression Analysis of the Influence of Depression on the Relationship between Internalized HIV Stigma and Disclosure
In the analysis of general HIV disclosure (see Table 3 ), higher internalized HIV stigma was significantly associated with not disclosing HIV status to most people in step 1, as well as in step 2 with clinical depression added to the model; depression was not associated with disclosure in step 2. In the third step, with the stigma by depression interaction in the model, both internalized HIV stigma and clinical depression were negatively correlated with disclosure to most people, and the interaction term was positively associated with disclosure. In each step of the analysis, the only two covariates associated with general disclosure were work status and clinic site; working was associated with not disclosing to most people, while attending any of the three rural clinics was associated with having disclosed to most people in comparison to participants attending the Kampala site. To better understand the relationship between the interaction of stigma and depression, and general disclosure, separate regression models were conducted for the subgroup of participants with clinical depression and those not depressed (see Table 4 ). In these models, only internalized HIV stigma and the demographic and background covariates were included as independent variables. Among the non-depressed patients, the odds of disclosing HIV status to most people was reduced by 91% [O.R. (95% CI) = 0.09 (0.06, 0.13)] with each unit increase of internalized HIV stigma. While among the depressed subgroup, the relationship between stigma and general disclosure was still strong, but the magnitude of the relationship was less, as the odds of disclosure was reduced by 72% with each unit increase of stigma [O.R. (95% CI) = 0.28 (0.14, 0.57)].
In the analysis of HIV disclosure to primary partner (see Table 5 ), higher internalized HIV stigma was significantly associated with non-disclosure to the partner in all 3 steps, while neither clinical depression nor the interaction of stigma and depression was associated with disclosure. The odds of having disclosed to one's primary partner reduced by 55% to 62% for each unit increase of internalized HIV stigma. In each step of the analysis, the only two covariates associated with disclosure to partner were age and attending the Mukono clinic; older age was associated with having disclosed to one's partner, while attending the Mukono clinic was associated with nondisclosure to the partner in comparison to participants attending the Kampala site.
We did not include HIV status of the partner in this model, because the bivariate results showed that almost all respondents who knew the HIV status of their partner had disclosed; hence, with the strength of this relationship the inclusion of this variable in the model would have distorted the observed relationships between disclosure and the other variables. However, it is important to acknowledge that the regression model findings do not account for the HIV status of the partner.
Discussion
In our study a substantial proportion of respondents kept their HIV status a secret to most people or sexual partners. Non-disclosure of HIV status to most people was associated with higher internalized HIV stigma and depression while disclosing to most people was negatively correlated with both stigma and depression. However, in multivariate analysis, only stigma remained independently associated with both types of disclosure, while clinical depression was associated with non-disclosure to most people, but not disclosure to primary partner, and only when the interaction of stigma and depression were included in the model. Further analysis showed that internalized HIV stigma was more strongly associated with general disclosure among participants who were not depressed. This is contrary to our hypothesis that depression would increase a person's vulnerability to stigma, thus enhancing the stigma as a barrier to disclosure. The explanation to this finding may lie in the strong relationship between depression and internalized stigma, as both are types of mental health measures and the variance in disclosure that each explains likely overlaps. Therefore, when depression is not present (i.e., among those not depressed) it results in stigma explaining more of the disclosure variance as it does not have to share some of the explained variance with depression. Previous research have shown that HIV positive individuals have difficulty disclosing their HIV status to significant others [34] . Varying rates of HIV non-disclosure ranging from 5.5% -83% have been reported in different sub populations across Africa [5] [10] [20] [22] [35]- [37] . HIV status disclosure is influences by the type of partnership [9] [20] [22] , type of marriage [37] , whether the person being disclosed to has a known positive status [20] [22] [38] , the number of lifetime sex partners [13] and fears of abandonment, discrimination. Longitudinal studies have found that stigma is associated with lower likelihood of disclosure to sexual partners, friends, and family [39] .
The extent to which people living with HIV/AIDS endorse the negative beliefs associated with HIV as true of themselves (internalize the HIV stigma), is an important consideration when examining reasons for nondisclosure. Previous research have shown that negative feelings for example shame about one's HIV status make it difficult for people living with HIV to tell others about their disease [40] [41] . Internalized stigma shapes when, how, and to whom to disclose [42] [43] . It is argued that self-disclosure decreases the ability to control second-hand disclosure by others, which may lead to stigmatizing consequences [44] . People living with HIV make disclosure decisions after weighing the pros and cons associated with serostatus disclosure [11] [45] . Hence nondisclosure according to Emlet, can be viewed as an act of protective silence [46] .
In each step of the analysis in our study, the only two covariates associated with disclosure to partner were age and attending the Mukono clinic; older age was associated with having disclosed to one's partner, while attending the Mukono clinic, which is more rural clinic was associated with nondisclosure to the partner in comparison to participants attending the Kampala site.
Studies that have examined the relationship between age and HIV disclosure have presented mixed results. These findings are consistent with those previously reported by O'Brien [47] , but contradicts findings of other studies conducted in Africa [14] [35] [48] . Lower rate of disclosure to sexual partner among younger individuals have been attributed to greater level of dependence on partner among younger individuals rendering them more susceptible to fears of isolation and of loss of economic support from a partner [5] .
We found that people attending more rural clinics were less likely to disclosure HIV status compared to people attending urban clinics. This can either be due to higher level of stigma in the rural area or the communal nature of relationship which makes it difficult to control second hand disclosure. Studies that have assessed patterns of disclosure by residence have reported mixed findings. Some studies have attributed this pattern of disclosure to cultural norms where conservative nature of cultural norms that may contribute to stigmatization for people living with HIV and influence disclosure decisions [49] [50] . Other have focused on the size of the community where a person resides in relation to the level of disclosure stigma experienced [50] [51] .
The results of this study are limited by several aspects of the study design. First, we used baseline data, in which, we did cross sectional analysis, hence using the current results, we unable to make definitive causal statements. Second, our sample consisted of a clinical sample of people living with HIV on antiretroviral treatment. All the participants were engaged in HIV care, and attending a program that requires its clients to have disclosed to someone in his/her social network before being prescribed antiretroviral therapy, so that they have someone who can be their treatment supporter. Such sample is likely to have lower levels of internalized stigma than HIV-infected individuals not in care. Therefore, the results cannot be considered representative of all persons living with HIV in Uganda or Sub-Saharan Africa.
Conclusion
In conclusion, our findings show a strong negative relationship between internalized HIV stigma and disclosure of HIV in general and to primary sexual partners. Depression, another indicator of psychological well-being and which was related to internalized stigma, was also negatively associated with disclosure, but only in bivariate analysis. Internal stigma is actually more strongly related to disclosure among non-depressed individuals, but it's not clear whether this is an artifact of the collinearity between depression and stigma, or that stigma has less of an influence on disclosure in the context of depression. What is clear is that internalized stigma appears to play a large role in HIV disclosure decision making and that interventions to reduce internalized HIV stigma may aid in efforts to increase HIV disclosure and thus decrease secondary transmission of HIV.
